Cancers that show overexpression or dysregulation of the MYC oncogene are particularly prone to genomic instability due to the prominent effect that MYC has as an oncoprotein transcription factor in facilitating expression of genes needed for cell cycle phase progression and mitotic cell fate [7]. The gene discussed is MYC; the disease is cancer.